Gelonghui, January 2丨Melande (688273.SH) Investor Relations Activity Record Sheet shows that the company continues to invest in research and development of new pelvic floor rehabilitation technology and new products to accelerate the launch of new products and the iterative upgrading of old products. It is expected that in the first quarter of 2024, 3 new pelvic floor rehabilitation line products will be launched.

(1) Second generation pelvic floor biostimulation feedback instrument. We have integrated multiple physiological indicators into second-generation new products, improved diagnostic efficiency and accuracy, and helped improve the pertinence and effectiveness of subsequent intelligent treatment plans.

(2) Pelvic floor ultrasound imaging system. We will launch a new pelvic floor imaging product, which can meet the clinical needs of one-stop access to visual test data.

(3) Pelvic floor split magnet. On the basis of the original pelvic floor magnets, we will launch split magnetic products to enrich the pelvic floor magnetic product line to meet more clinical demand scenarios.

The launch of the three new pelvic floor products will build an overall AI-based pelvic floor rehabilitation solution, integrating functions such as automatic detection, automatic reporting, and automatic generation of plans that have already been implemented in the early stages, and combined with more data (including clinical indicators such as pelvic floor structure and functionality) to elevate the pelvic floor intelligent diagnosis and treatment system to a new stage, optimize the convenience and effectiveness of clinical applications, and complete the evolution from product solutions to scenario-based solutions.